{"id":"NCT00643851","sponsor":"AstraZeneca","briefTitle":"An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets","officialTitle":"A Multicenter, Randomized, Double-Blind, Active Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin as Initial Therapy as Compared With Dapagliflozin Monotherapy and Metformin Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-06","primaryCompletion":"2009-08","completion":"2009-08","firstPosted":"2008-03-26","resultsPosted":"2017-02-23","lastUpdate":"2023-01-30"},"enrollment":994,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes"],"interventions":[{"type":"DRUG","name":"Dapagliflozin","otherNames":["BMS-512148"]},{"type":"DRUG","name":"Metformin XR","otherNames":[]}],"arms":[{"label":"Arm 1","type":"EXPERIMENTAL"},{"label":"Arm 2","type":"EXPERIMENTAL"},{"label":"Arm 3","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this clinical research study is to learn if initiating treatment with BMS-51248 (Dapagliflozin) in combination with metformin XR can improve diabetes control in patients with Type 2 Diabetes who do not receive any pharmacological treatment for diabetes, when compared to initial treatment with monotherapy dapagliflozin or metformin XR. The safety of this treatment will also be studied","primaryOutcome":{"measure":"Adjusted Mean Change From Baseline in Hemoglobin A1C (HbA1c) at Week 24 (Last Observation Carried Forward [LOCF])","timeFrame":"From Baseline to Week 24","effectByArm":[{"arm":"Dapagliflozin 5 mg + Metformin XR","deltaMin":-2.05,"sd":0.0892},{"arm":"Dapagliflozin 5 mg","deltaMin":-1.19,"sd":0.0866},{"arm":"Metformin XR","deltaMin":-1.35,"sd":0.0868}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"},{"comp":"OG000 vs OG002","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":99,"countries":["United States","Mexico","Philippines","Puerto Rico","Russia","South Korea","Ukraine"]},"refs":{"pmids":["22413962","26894924"],"seeAlso":["http://onlinelibrary.wiley.com/doi/10.1111/j.1742-1241.2012.02911.x/epdf"]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":194},"commonTop":["DIARRHOEA","UPPER RESPIRATORY TRACT INFECTION","URINARY TRACT INFECTION","DYSLIPIDAEMIA","NAUSEA"]}}